Veröffentlichungen

Leitlinien:

  • National Institute for Health and Care Excellence (NICE) Medical Technologies Guidance (MTG26): UroLift for lower urinary tract symptoms of benign prostatic hyperplasia.  September 2015
    https://www.nice.org.uk/guidance/mtg26
  • National Institute for Health and Care Excellence (NICE) Interventional Procedures Guidance (IPG475):  Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia. January 2014
    https://www.nice.org.uk/guidance/ipg475

Meta-Analysen:

  • Roehrborn C, Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin N Am 2016
    Abstract ansehen

  • Shore N, A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia. Curr Bladder Dysfunct Rep 2014.
    Vollständigen Artikel ansehen
  • Perera M, et al., Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol 2015 article and addendum
    Abstract ansehen

 

Klinische Studien:

  • Eure G, Gange S, Walter P, Khan A, Chabert C, Mueller T, Cozzi P, Patel M, Freedman S, Chin P, Ochs S, Hirsh A, Trotter M, and Grier D. Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study. J of Endourology 2019.
    Vollständigen Artikel ansehen
  • Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 2017; 24(3); 8802-8813.
    Vollständigen Artikel ansehen
  • Gratzke C, Barber N, Speakman M, Berges R, Wetterauer U, Greene D, Sievert KD, Chapple C, Sonksen J. Prostatic urethral lift (PUL) vs transurethral resection of the prostate (TURP): 2 year results of the BPH6 prospective, multi-center, randomised study. BJU Int. 2017; 119: 767-775.
    Vollständigen Artikel ansehen
  • Shah BB, Tayon K, Madiraju SG, Carrion RE, Perito P. Prostatic urethral lift: does size matter? J Endourol 2018; DOI: 10.1089/end.2017.0855.
  • Keehn A, Fram E, Garg M, Maria P. UroLift in place of fiducial markers for patients with benign prostatic hyperplasia undergoing external beam radiation therapy. Urology 2017; 104: 230-234.
  • Walsh L. State of the art: advanced techniques for prostatic urethral lift for the relief of prostate obstruction under local anesthesia. Can J Urol 2017; 24(3); 8859-8864.
    Vollständigen Artikel ansehen
  • Schoenthaler M, Sievert KD, Schoeb DS, Miernik A, Kunit T, Hein S, Herrmann TRW, Wilhelm K. Combined prostatic urethral lift and remodeling of the prostate and bladder neck: a modified transurethral approach in the treatment of lower urinary tract obstruction. W J Urol 2018;
    Abstract ansehen
  • Bardoli AD, Taylor WS, Mahmalji W. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature. Aging Male 2017; 20(3): 192-197.
  • Rukstalis D, Rashid P, Bogache W, Tutrone R, Barkin J, Chin P, Woo H, Cantwell A, Cowan B, Bolton D. Two year durability after crossover to the prostatic urethral lift from randomized, blinded sham. BJUI 2016; doi: 10.1111/bju.13666.
    Vollständigen Artikel ansehen
  • Roehrborn CG. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin N Am 2016; 43: 357-369.
    Abstract ansehen 
  • Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 2015; 22(3); 7772-7782.
    Vollständigen Artikel ansehen
  • Sønksen J, Barber NJ, Speakman M et al. Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study. Eur Urol 2015; 68; 643-652.
    Vollständigen Artikel ansehen
  • Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB. Durability of the prostatic urethral lift: two year results of the L.I.F.T. Study. Urology Practice 2015 (2); 1-7.
    Vollständigen Artikel ansehen
  • Shore N, Freedman S, Gange S, Moseley W, Heron S, Tutrone R, Brown T, Barkin J. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urology 2014; 21(1): 7094-7101.
    Vollständigen Artikel ansehen
  • Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, Chin PT, Woo HH. Multi-Center prospective crossover study of the prostatic urethral lift for the treatment of LUTS secondary to BPH. BJUI 2013; 113: 615-622.
    Abstract ansehen 
  • McVary KT, Gange SN, Shore ND, Bolton DM, Cowan BE, Brown BT, Te AE, Chin PT, Rukstalis DB, Roehrborn CG. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of the prostatic urethral lift. J Sex Med 2014; 11: 279-287
    Abstract ansehen 
  • Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB. Multi-Center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: the L.I.F.T. study. J Urol 2013; 190: 2162-2167.
    Abstract ansehen 
  • McNicholas TA, Woo HH, Chin PT, Bolton D, Fernandez-Arjona M, Sievert, KD, Schoenthaler M, Wetterauer U, Vrijhof EJEJ, Gange S, Montorsi F: Minimally invasive Prostatic Urethral Lift: surgical technique and multinational study. Eur Urol 2013; 64: 292-299.
    Abstract ansehen 
  • Chin PT, Bolton DM, Rashid JG, Thavaseelan J, Yu RJ, Roehrborn CG, Woo HH. Prostatic Urethral Lift:  Two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia.  Urology 2012; 79: 5-11.
    Abstract ansehen 
  • Barkin J Giddens J, Ineze P, Casey R, Richardson S, Gange S. UroLift system for the relief of prostate obstruction under local anesthesia.  Can J Urology 2012; 19: 6217-6222.
    Abstract ansehen 
  • Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, Thavaseelan J, McVary KT. Preservation of sexual function with the prostatic urethral lift:  a novel treatment for lower urinary tract symptoms secondary to benign prostatic hypertrophy.  J Sex Med 2012; 9: 568-575.
    Abstract ansehen 
  • Woo HH, Chin PT, McNicholas TA, Harscharan G, Plante MK, Bruskewitz RC, Roehrborn CG. Safety and feasibility of the prostatic urethral lift: a novel minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hypertrophy (BPH).  BJU Int 2011; 108: 82-88.
    Abstract ansehen 
  • Rukstalis D, Grier D, Stroup S, Tutrone R, deSouza E, Freedman S, David R, Kaminetsky J, Eure G. Prostatic urethral lift (PUL) for obstructive median lobes: 12 month results of the MedLift study. Prostate Can Prost Dis 2018;
    Abstract ansehen 
  • Sievert KD, Schonthaler M, Berges R, Toomey P, Drager D, Herlemann A, Miller F, Wetterauer U, Volkmer B, Gratzke C, Amend B. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World J Urol;
    Vollständigen Artikel ansehen
  • Biswal NC, Swann B, McKenna MG, Singh R. UroLift as a surrogate for fiducial markers in IGRT planning of prostate cancer in BPH patients. Practical Rad Onc 2018; 8: e231-e233.
  • Bozkurt A, Karabakan M, Keskin E, Hirik E, Balci MBC, Nuhoglu B. Prostatic urethral lift: a new minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Int 2016; 96: 202-206.
  • Beurrier S, Peyromaure M, Belas O, Delongchamps NB. La pose d’implants intra-prostatiques UroLift est-elle une alternative chez les patients ayant une hyperplasie benigne de la prostate? Resultats initiaux et facteurs predictifs d’echec. Progres en Urologie 2015; 25; 523-529.
  • Akin Y, Bozkurt A, Oguz Keles M, Gulmez H, Sahin M, Nuhoglu B. Benign prostat hiperplazisi nin yeni minimal invasive tedavi secenegi: prostat icerisine UroLift uygulamasi, erken donem sonuclari ile Turkiye den ilk vaka serisi. JAREM 2013; 3; 74-78.
  • Garrido Abad P, Coloma del Peso A, Sinues Ojas B, Fernandez Arjona F. UroLift, un Nuevo tratmiento minimament invasive para los sintomas de tracto urinario inferior secudarios a HBP. Resutados preliminaries. Urologia Neurologica y Urodinamico: Arch. Esp. Urol. 2013; 66(6): 584-591.
    Abstract ansehen 
  • Delongchamps NB, Conquy S, Defontaines J, Zerbib M, Peyromaure M. Pose d’implants UroLift intra-prostatiques pour hyperplasie benigne de la prostate: resultats preliminaires des quatre premiers cas realizes en France. Progres en urologie 2012; 22: 590-597.
    Abstract ansehen 


Reviews:

  • Rieken M, Antunes-Lopes T, Geavlete B, Marcelissen T. What is new with sexual side effects after transurethral male lower urinary tract symptom surgery? Eur Urol 2018;
    Abstract ansehen 
  • Giona S, Ganguly I, Muir G. Urologists’ attitudes to sexual complications of LUTS/BPH treatments. W J Urol 2018;
    Abstract ansehen 
  • Magistro G, Weinhold P, Stief CG, Gratzke C. The new kids on the block: prostatic urethral lift (UroLift) and convective water vapor energy ablation (Rezum). Curr Opin Urol 2018; DOI:10.1097/MOU.0000000000000502.
  • Gupta NK, Gange SN, McVary KT. New and emerging technologies in treatment of lower urinary tract symptoms from benign prostatic hyperplasia. Sex Med Rev 2018: 1-8.
  • Magistro G, Stief CG, Woo HH. Mini review: what’s new with UroLift? Eur Urol 2018;
    Abstract ansehen 
  • Chung ASJ, Woo HH. Update on minimally invasive surgery and benign prostatic hyperplasia. Asian J Urol 2018; 5: 22-27.
    Vollständigen Artikel ansehen
  • Magistro G, Chapple CR, Elhilali M, Gilling P, McVary KT, Roehrborn CG, Stief CG, Woo HH, Gratzke C. Emerging minimally invasive treatment options for male lower urinary tract symptoms. Eur Urol 2017; 72:986-997.
  • Albisinni S, Aoun F, Roumeguere T, Porpiglia F, Tubaro A, De Nunzio C. New treatment strategies for benign prostatic hyperplasia in the frail elderly population: a systematic review. Minerva Urol Nefrol 2017; 69(2): 119-132.
  • Pushkaran A, Stainer V, Muir G, Shergill IS. UroLift – minimally invasive surgical BPH management. Expert Review 2017; 14(3): 223-228.
  • Roehrborn CG. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin N Am 2016; 43: 357-369.
    Abstract ansehen 
  • McNicholas TA. Benign prostatic hyperplasia and new treatment options –a critical appraisal of the UroLift system. Medical Devices: Evidence and Research 2016; 9; 115-123.
    Vollständigen Artikel ansehen
  • Chung A, Woo HH. Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered? Curr Opin Urol 2016; 26(1): 42-48.
  • Jones P, Rajkumar GN, Ral BP, Aboumarzouk OM, Cleaveland P, Srirangam SJ, Somani BK. Medium-term outcomes of UroLift (minimum 12 months follow-up): Evidence from a systematic review. Urology 2016; 97: 20-24.
  • Jones P, Rai BP, Aboumarzouk OM, Somani BK. Prostatic urethral lift vs prostate arterial embolization: novel nonablative strategies in the management of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2016; 87: 11-17.
  • Marra G, Sturch P, Oderda M, Tabatabaei S, Muir G, Gontero P. Systematic review of the lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men’s ejaculatory function: Time for a bespoke approach? Int J Urol 2016; 23(1): 22-35.
    Vollständigen Artikel ansehen
  • Tsui JF, Dixon CM. UroLift: a new face of minimally invasive surgical technique for benign prostatic hyperplasia? Curr Urol Rep 2016; 17(63):1-5. Magistro G, Stief CG, Gratzke C. New Intraprostatic injectables and prostatic urethral lift for male LUTS. Nature Rev Urol 2015; 12: 461-471.
  • Rukstalis DB. Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man. Can J Urol 2015; 22:67-74.
    Vollständigen Artikel ansehen
  • Sturch P, Woo HH, McNicholas TA, Muir G. Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking? BJUI 2015; 115: 186-187.
    Vollständigen Artikel ansehen
  • Garcia C, Chin P, Rashid P, Woo HH. Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia. Prostate Int 2015; 3: 1-5.
    Vollständigen Artikel ansehen
  • Aoun F, Marcelis Q, Roumeguere T. Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update. Res and Rep in Urol 2015; 7: 125-136.
    Vollständigen Artikel ansehen
  • Chughtai B, Kaplan S. Surgical treatment of benign prostatic hyperplasia – lift or laser? Urology Practice 2014 (1); 45-48.
    Vollständigen Artikel ansehen
  • Clarke JL. Optimizing population health and economic outcomes: innovative treatment for benign prostatic hyperplasia (BPH). Pop Health Mgt 2013; 16(2); S1-S13.
    Vollständigen Artikel ansehen
  • Payton S. Promising future for the prostatic urethral lift. Nature Rev. Urol 10, 677 (2013); published online 26 November 2013; doi:10.1038/nrurol.2013.267.
    Vollständigen Artikel ansehen
  • Larcher A, Broglia L, Lughezzani G, Mistretta F, Abrate A, Lista G, Fossati N, Sangalli M, Kuefner D, Cestari A, Buffi N, Lazzeri M, Guazzoni G, Montorsi F. Urethral lift for benign prostatic hyperplasia: a comprehensive review of the literature. Curr Urol Rep 21 JUN 2013;DOI:10.1007/s11934-013-0348-3.Bell J, Laborde E: Update on sexual impact of treatment for Benign Prostatic Hyperplasia. Curr Urol Rep 12 October 2012; http://DOI 10.1007/s11934-012-0278-5.
    Vollständigen Artikel ansehen
  • Batura D, Sahibzada I. TURP in the era of UroLift. Int Urol Nephrol. 2018;50(5):877-878. doi:10.1007/s11255-018-1833-x.
  • Magistro G, Stief C, Gratzke C. Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP). Curr Urol Rep. 2017;18(10). doi:10.1007/s11934-017-0725-4.
  • Lebdai S, Chevrot A, Doizi S et al. Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment. World J Urol. 2018;37(2):299-308. doi:10.1007/s00345-018-2368-6.
  • Patel R, Bariol S. National trends in surgical therapy for benign prostatic hyperplasia in Australia. ANZ J Surg. 2019. doi:10.1111/ans.15016.
  • Kaplan S. Re: Prospective, Randomized, Multinational Study of Prostatic Urethral Lift versus Transurethral Resection of the Prostate: 12-Month Results from the BPH6 Study. Journal of Urology. 2017;197(2):484-484. doi:10.1016/j.juro.2016.11.045.
  • Jones P, Rai B, Aboumarzouk O, Somani B. UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia. Ther Adv Urol. 2016;8(6):372-376. Doi:10.1177/1756287216671497.
    Vollständigen Artikel ansehen
  • Jones P, Rai B, Aboumarzouk O, Somani B. UroLift: a new chapter in benign prostate hyperplasia (BPH) therapy. Ann Transl Med. 2016;4(6):116-116. doi:10.21037/atm.2016.01.29.
    Vollständigen Artikel ansehen
  • Peyton C, Badlani G. The management of prostatic obstruction with urethral stents. Can J Urol. 2019. PMID: 26497347.
  • Bultitude M, Le Roux P. Re: Jens Sønksen, Neil J. Barber, Mark J. Speakman, et al. Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study. Eur Urol 2015;68:643–52. Eur Urol. 2016;69(3):e37-e38. doi:10.1016/j.eururo.2015.07.015
  • Roberts M, Perera M, Doi S, Bolton D. Re: Marlon Perera, Matthew J. Roberts, Suhail A.R. Doi, Damien Bolton. Prostatic Urethral Lift Improves Urinary Symptoms and Flow While Preserving Sexual Function for Men with Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. Eur Urol 2015;67:704–13. Eur Urol. 2015;68(3):e53-e54. doi:10.1016/j.eururo.2015.05.035
  • Pham H, Pranav S. Emerging newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy. Can J Urol. 2018. PMID: 29679999.
    Vollständigen Artikel ansehen
  • Ray A, Morgan H, Wilkes A, Carter K, Carolan-Rees G. The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2016;14(5):515-526. Doi:10.1007/s40258-015-0218-x.
    Vollständigen Artikel ansehen
  • Kaplan S. Re: Treatment of LUTS Secondary to BPH while Preserving Sexual Function: Randomized Controlled Study of Prostatic Urethral Lift. Journal of Urology. 2015;194(1):168-169. doi:10.1016/j.juro.2015.04.044.
  • Chughtai B, Te A, Kaplan S, Lee R. The Prostatic Urethral Lift Procedure: Enough Bang for the Buck?. Eur Urol. 2015;68(4):653-654. Doi:10.1016/j.eururo.2015.05.006.
  • Stone L. BPH6 results will lift the spirits of men with LUTS secondary to BOO. Nature Reviews Urology. 2015;12(6):299-299. doi:10.1038/nrurol.2015.115.
  • Kaplan S. The Prostate Urethral Lift: Will It Be Uplifting or Downgraded as a Treatment Strategy for Benign Prostatic Hyperplasia?. Eur Urol. 2015;67(4):714-715. doi:10.1016/j.eururo.2014.12.013.
  • Gupta S, Singh V, Goel A. Re: the prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. C. G. Roehrborn, S. N. Gange, N. D. Shore, J. L. Giddens, D. M. Bolton, B. E. Cowan, B. T. Brown, K. T. McVary, A. E. Te, S. S. Gholami, P. Rashid, W. G. Moseley, P. T. Chin, W. T. Dowling, S. J. Freedman, P. F. Incze, K. S. Coffield, F. D. Borges and D. B. Rukstalis J Urol 2013;190:2161-2167. J Urol. 2014. PMID: 25405255.
  • Gupta S. L.I.F.T. study: Prostatic urethral lift for the treatment of LUTS associated with BPH. Indian J Urol. 2014. PMID: 24744530.
  • Thiruchelvam N. Surgical therapy for benign prostatic hypertrophy/bladder outflow obstruction. Indian J of Urol. 2014;30(2):202. Doi:10.4103/0970-1591.126907.
  • Mavuduru R, Devana S, Nayak B, Gupta S, Singh V, Goel A. Re: The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia: The L.I.F.T. Study. Journal of Urology. 2014;191(6):1934-1936. doi:10.1016/j.juro.2013.10.150.
  • Ulchaker J, Martinson M. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. ClinicoEconomics and Outcomes Research. 2017;Volume 10:29-43. doi:10.2147/ceor.s148195.
    Vollständigen Artikel ansehen
  • Westhofen T, Magistro G, Stief C, Gratzke C. Das UroLift® System in der Behandlung des benignen Prostata-Syndroms (BPS). Aktuelle Urol. 2018;49(06):515-518. doi:10.1055/a-0759-9185.
  • Magistro G, Stief C, Gratzke C. Neue minimal-invasive Therapie des benignen Prostatasyndroms. Urologe. 2019;58(3):254-262. doi:10.1007/s00120-019-0876-7.
  • Magistro G, Stief C, Gratzke C. Minimal-invasive Therapie des benignen Prostatasyndroms. Urologe. 2016;55(11):1419-1432. doi:10.1007/s00120-016-0249-4.
  • Liang J, Lu Y. Prostatic urethral lift: A novel minimally invasive treatment for benign prostatic hyperplasia. Zhonghua Nan Ke Xue. 2016. PMID: 29019232
  • Liang J, Lu Y. Minimally invasive techniques in the treatment of benign prostatic hyperplasia: An update. Zhonghua Nan Ke Xue. 2016. PMID: 27416660.
  • Sánchez-Gómez L, Polo-deSantos M, Gómez-Sancha F, Luengo-Matos S. Efectividad y seguridad del evisio Urolift® para el tratamiento de los síntomas de la evision ia benigna de próstata: evision sistemática. Actas Urológicas Españolas. 2015;39(5):311-319. Doi:10.1016/j.acuro.2014.05.010.
  • Arenas da Silva LF, Schonthaler M, Cruz F, Gratzke C, Zumbe J, Stenzl A, Amend B, Sievert KD. Neue behandlungskonzepte von symptomen des unteren harntraktes beim mann. Urologue 2012; 51: 1697-1702.
    Vollständigen Artikel ansehen

 

Fallstudien/Berichte:

  • Bardoli, Antonio Devanti, et al. “Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report.” Journal of Men's Health, vol. 14, no. 1, 1 Jan. 2018, pp. e11–e13., doi:10.22374/1875-6859.14.1.3.
    Vollständigen Artikel ansehen
  • Jones, Adam, Phan, YC, Mahmalji, Wasim. “UroLift for the treatment of lower urinary tract symptoms in a patient with AMS 700 penile prosthesis: The first reported case.” Journal of Endoluminal Endourology, 14 Jan 2019; DOI:10.22374/jeleu.v2i1.31.
    Vollständigen Artikel ansehen
  • Iqbal M, Jones R, Hughes S, Shergill I. Low power HOLEP after failed urolift: A case report using 50 Watt laser. Urol Case Rep. 2018;16:114-115. doi:10.1016/j.eucr.2017.11.029.
    Vollständigen Artikel ansehen
  • Tapping C, Little M, Boardman P. Successful Prostatic Artery Embolization following UroLift Device Failure. Journal of Vascular and Interventional Radiology. 2017;28(9):1275-1276. doi:10.1016/j.jvir.2017.02.028.
  • Kuo H, Liao C. Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasia. Tzu Chi Medical Journal. 2017;29(1):1. doi:10.4103/tcmj.tcmj_2_17.
    Vollständigen Artikel ansehen